

Baxter tops Q3 consensus with 58 cents EPS and $2.976 billion in sales, lifting fiscal 2026 profit and revenue guidance above Wall Street forecasts.
You can purchase shares of Baxter International (NYSE:BAX) through any online brokerage.
Other companies in Baxter International’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Baxter International has a consensus price target of $25.54.
The stock price for Baxter International (NYSE: BAX) is $25.7597 last updated November 4, 2026 at 5:05 AM EST.
There are no upcoming dividends for Baxter International.
Baxter International does not have any upcoming earnings scheduled.
There is no upcoming split for Baxter International.
Baxter International is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical...